Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1280776/000128077618000100/a8-kcoverpage102618.htm
April 2019
April 2019
March 2019
March 2019
January 2019
January 2019
January 2019
November 2018
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1280776/000128077618000100/a8-kcoverpage102618.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Vital Therapies Inc.
Vital Therapies Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Ticker: VTLEvents:
CIK: 1280776
Form Type: 8-K Corporate News
Accession Number: 0001280776-18-000100
Submitted to the SEC: Fri Oct 26 2018 4:56:07 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Thursday, October 25, 2018
Industry: Pharmaceutical Preparations